Studies comparing antibody and T cell responses generated against VOCs in COVID-19 convalescents and recipients of the Moderna and Pfizer-BioNTech vaccines showed variable degrees of impairment in antibody responses, but the preservation of CD4+ and CD8+ T cell responses (208, 209). The gene discussed is CD8A; the disease is COVID-19.